Justin M. Hall
2021 - NovaBay Pharmaceuticals
In 2021, Justin M. Hall earned a total compensation of $795.5K as CEO, GC and Chief Compliance Officer at NovaBay Pharmaceuticals, a 6% increase compared to previous year.
Compensation breakdown
| Bonus | $70,000 |
|---|---|
| Salary | $328,667 |
| Stock Awards | $395,000 |
| Other | $1,854 |
| Total | $795,521 |
Hall received $395K in stock awards, accounting for 50% of the total pay in 2021.
Hall also received $70K in bonus, $328.7K in salary and $1.9K in other compensation.
Rankings
In 2021, Justin M. Hall's compensation ranked 9,487th out of 12,397 executives tracked by ExecPay. In other words, Hall earned more than 23.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,487 out of 12,397 | 24th |
Division Manufacturing | 4,202 out of 5,492 | 24th |
Major group Chemicals And Allied Products | 1,860 out of 2,367 | 21st |
Industry group Drugs | 1,651 out of 2,090 | 21st |
Industry Pharmaceutical Preparations | 1,226 out of 1,537 | 20th |
Source: SEC filing on March 30, 2022.
Hall's colleagues
We found two more compensation records of executives who worked with Justin M. Hall at NovaBay Pharmaceuticals in 2021.
News
NovaBay Pharmaceuticals CEO Justin Hall's 2021 pay rises 6% to $796K
March 30, 2022
NovaBay Pharmaceuticals CEO Justin Hall's 2020 pay jumps 129% to $747K
April 7, 2021
NovaBay Pharmaceuticals CFO Jason Raleigh receives $334K in 2019
April 15, 2020
YRC Worldwide CEO Darren Hawkins' 2018 pay jumps 439% to $4.4M
April 25, 2019
NovaBay Pharmaceuticals CEO John McGovern's 2018 pay jumps 64% to $742K
April 19, 2019